PDCD1 and pneumonitis: In line with these results, a previous systematic review reported that anti-PD1 agents showed a higher rate of irAEs and pneumonitis than PD-L1 inhibitors [31], whereas a recent MA did not find significant differences in the incidence of pneumonitis between this ICIs subgroups [30].